COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital

被引:6
|
作者
Ranhel, David [1 ]
Ribeiro, Ana [1 ]
Batista, Judite [1 ]
Pessanha, Maria [1 ]
Cristovam, Elisabete [1 ]
Duarte, Ana [1 ]
Dias, Ana [1 ]
Coelho, Luis [1 ]
Monteiro, Filipa [1 ]
Freire, Pedro [1 ]
Verissimo, Cristina [2 ]
Sabino, Raquel [2 ,3 ]
Toscano, Cristina [1 ]
机构
[1] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal
[2] Natl Hlth Inst Dr Ricardo Jorge, Infect Dis Dept, P-1649016 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1649028 Lisbon, Portugal
关键词
COVID-19; intensive care unit; Aspergillus; invasive pulmonary aspergillosis; COVID-19-associated invasive pulmonary aspergillosis; COVID-19;
D O I
10.3390/jof7100881
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report
    Imoto, Waki
    Himura, Hoshi
    Matsuo, Kenji
    Kawata, Sae
    Kiritoshi, Ayako
    Deguchi, Ryo
    Miyashita, Masahiro
    Kaga, Shinichiro
    Noda, Tomohiro
    Yamamoto, Katsumi
    Yamada, Koichi
    Uchida, Kenichiro
    Nishimura, Tetsuro
    Yamamoto, Hiromasa
    Mizobata, Yasumitsu
    Kakeya, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (06) : 911 - 914
  • [32] Unusual manifestation of COVID-19-associated pulmonary aspergillosis: A case report
    Albaji, Maryam
    Fattahi, Mohammad Reza
    Iranmehr, Arad
    CLINICAL CASE REPORTS, 2022, 10 (08):
  • [33] COVID-19-associated pulmonary aspergillosis in hemodialysis patients
    Yamaoka, Mai
    Banshodani, Masataka
    Muraoka, Shiro
    Tanaka, Kenta
    Kimura, Ayaka
    Tani, Hiroki
    Hashimoto, Shinji
    Shiraki, Nobuaki
    Shintaku, Sadanori
    Moriishi, Misaki
    Tsuchiya, Shinichiro
    Masaki, Takao
    Kawanishi, Hideki
    CLINICAL KIDNEY JOURNAL, 2022, 15 (05) : 985 - 991
  • [34] CLINICAL CHARACTERISTICS OF COVID-19-ASSOCIATED PULMONARY ASPERGILLOSIS
    Kim, Yoon-Seop
    Lee, Suyeon
    Ahn, Jee Hwan
    Huh, Jin Won
    CHEST, 2023, 164 (04) : 843A - 843A
  • [35] Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
    Permpalung, Nitipong
    Maertens, Johan
    Marr, Kieren A.
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : 766 - 767
  • [36] COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City
    Jiang, Zhaofang
    Chen, Shuyan
    Zhu, Qing
    Xiao, Yanyu
    Qu, Jiuxin
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (02) : 222 - 227
  • [37] Is COVID-19-associated pulmonary aspergillosis (CAPA) a myth? Frequency of Aspergillus detection from respiratory samples in intensive care unit patients with and without COVID-19
    Kuemmig, T.
    Esse, J.
    Herbst, L.
    Castellanos, I.
    Strauss, R.
    Geissdoerfer, W.
    Mihai, S.
    Rakova, N.
    Cipa, F.
    Pflaum, D.
    Werblow, M.
    Lang, A. K.
    Bremer, F.
    Ganslmayer, M.
    Willam, C.
    Held, J.
    MYCOSES, 2021, 64 : 3 - 3
  • [38] COVID-19 Associated Pulmonary Aspergillosis: A Case Series
    Yulianti, Mira
    Johan, Christian
    Tenda, Eric Daniel
    Singh, Gurmeet
    Herikurniawan
    Wijaya, I. Putu Eka Krisnha
    ACTA MEDICA INDONESIANA, 2022, 54 (02) : 292 - 298
  • [39] COVID-19-Associated Pulmonary Aspergillosis in a Series of Complete Autopsies from the Brazilian Amazon
    Farias, Maria Eduarda
    Santana, Monique Freire
    Ferreira, Luiz
    Borba, Mayla
    Silva-Neto, Joao
    Brito-Sousa, Jose Diego
    Baia-da-Silva, Djane Clarys
    Joao, Guilherme Pivoto
    Val, Fernando
    Simao, Mariana
    Souza, Joao Vicente
    Naveca, Felipe
    Melo, Gisely
    Monteiro, Wuelton
    Lacerda, Marcus
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 106 (02): : 571 - 573
  • [40] Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital
    Paramythiotou, Elisabeth
    Dimopoulos, George
    Koliakos, Nikolaos
    Siopi, Maria
    Vourli, Sophia
    Pournaras, Spyros
    Meletiadis, Joseph
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1779 - 1792